Showing results (481-490 of 607) with videos related to

Sort By:
Pageof 61
European Journal of Medicinal Chemistry|April 17, 2014
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysisJulie Charton, Marion Gauriot, Qing Guo, et al.
Journal of the American College of Cardiology|February 4, 2026
MASLD, MASH, and the CKM Spectrum: A Roadmap for Multiorgan Clinical Trial DesignFaiez Zannad, Muhammad Shahzeb Khan, Nisha Bansal, et al.
Journal of Lipid Research|June 30, 2019
FXR overexpression alters adipose tissue architecture in mice and limits its storage capacity leading to metabolic derangementsTim van Zutphen, Johanna H M Stroeve, Jiufang Yang, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese SubjectsVanessa Legry, Sven Francque, Joel T Haas, et al.
The Journal of Clinical Investigation|March 18, 2006
Intestinal ABCA1 directly contributes to HDL biogenesis in vivoLiam R Brunham, Janine K Kruit, Jahangir Iqbal, et al.
Gastroenterology|June 21, 2008
Regulation of bile acid synthesis by the nuclear receptor Rev-erbalphaHélène Duez, Jelske N van der Veen, Christian Duhem, et al.
Cardiovascular Research|January 12, 2008
Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overloadPascal J H Smeets, Birgit E J Teunissen, Peter H M Willemsen, et al.
Molecular Metabolism|April 7, 2020
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatmentBen Arpad Kappel, Lorenzo De Angelis, Michael Heiser, et al.
American Journal of Hypertension|June 10, 2011
Association between a thyroid hormone receptor-α gene polymorphism and blood pressure but not with coronary heart disease riskLouisa Goumidi, Karine Gauthier, Vanessa Legry, et al.
Frontiers in Endocrinology|September 19, 2022
High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablationRaphaël Decoin, Laura Butruille, Thomas Defrancq, et al.
Pageof 61